Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

[Osteogenetic capacity of cross-linked adjustable anti-tuberculosis drug sustained-release artificial composite].

Xi YH, Xue MT, Ye XJ, Xu N, Qu JT, Liu XL, He HL.

Zhonghua Yi Xue Za Zhi. 2013 May 21;93(19):1494-8. Chinese.

PMID:
24029576
2.

[Study on the rifampicin polylactic acid microspheres for lung targeting].

Zhang W, Jiang X, Zhu C, Hu J.

Yao Xue Xue Bao. 1998;33(1):57-61. Chinese.

PMID:
11938937
3.

[Promoting of angiogenesis and osteogenesis in radial critical bone defect regions of rabbits with nano-hydroxyapatite/collagen/PLA scaffolds plus endothelial progenitor cells].

Wu DJ, Hao AH, Zhang C, Cui FZ, Wang XW, Gao CZ, Zhou CJ, Liu JL, Qiao Y, Ma SZ.

Zhonghua Yi Xue Za Zhi. 2012 Jun 19;92(23):1630-4. Chinese.

PMID:
22944134
4.

[The effect of modified bone morphogenetic protein-2 polylactic acid nanospheres sustained-release system on promoting mandibular defect repair].

Luo F, Lu L, Zeng Y, Zhao Z, Zhu J, Zhang G.

Hua Xi Kou Qiang Yi Xue Za Zhi. 2013 Apr;31(2):154-7. Chinese.

5.

Enhanced bone formation in large segmental radial defects by combining adipose-derived stem cells expressing bone morphogenetic protein 2 with nHA/RHLC/PLA scaffold.

Hao W, Dong J, Jiang M, Wu J, Cui F, Zhou D.

Int Orthop. 2010 Dec;34(8):1341-9. doi: 10.1007/s00264-009-0946-3. Epub 2010 Feb 7.

6.

[Experimental study of repairing femoral bone defects with nHA/RHLC/PLA scaffold composite with endothelial cells and osteoblasts in canines].

Lü YM, Cheng LM, Pei GX, Cai Z, Pan L, Su J, Zhang KH, Guo LL, Yu QS, Guo YR.

Zhonghua Yi Xue Za Zhi. 2013 May 7;93(17):1335-40. Chinese.

PMID:
24029485
7.

[Comparison of effect between vascularization osteogenesis and membrane guided osteogenesis in bone repair by tissue engineered bone with pedicled fascial flap packing autologous red bone marrow].

Yang X, Zhang L, Meng X, Wang Y, Shi W, Du Y, Hu Z, Yin Y.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2011 Jun;25(6):729-35. Chinese.

PMID:
21735789
8.
9.

[Effect of sustained-release basic fibroblast growth factor on healing of bile duct defect in pigs].

Tao L, Li Q, Ren H, Dai J, Ding Y.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2013 Feb;27(2):212-8. Chinese.

PMID:
23596691
10.

Comparative study between coral-mesenchymal stem cells-rhBMP-2 composite and auto-bone-graft in rabbit critical-sized cranial defect model.

Hou R, Chen F, Yang Y, Cheng X, Gao Z, Yang HO, Wu W, Mao T.

J Biomed Mater Res A. 2007 Jan;80(1):85-93.

PMID:
16960828
11.

[Metabonomic profile of urine from rats administrated with different treatment period of rifampin].

Liao Y, Peng SQ, Yan XZ, Chen HB, Zhang LS.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Dec;30(6):696-702. Chinese.

12.

[Clinical application of line probe assay (LiPA) for rifampicin (RFP)-resistant gene examination in sputum from tuberculosis patients].

Inagaki T, Yagi T, Ichikawa K, Nakagawa T, Moriyama M, Uchiya K, Nikai T, Ogawa K.

Kekkaku. 2010 Sep;85(9):703-9. Japanese.

PMID:
20960950
13.

[Experimental study on repairing composite defect of mandible and skin by prefabricated musculocutaneous flap including ectopic bone].

Xu J, Wang H, Li Y, Tan W, Lin J, Wang W.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2008 Feb;22(2):139-44. Chinese.

PMID:
18365606
14.

[Repair of articular cartilage defect with poly-lactide-co-glycolide loaded with recombinant human bone morphogenetic protein in rabbits].

Cui Y, Wu J, Hu Y.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2007 Nov;21(11):1233-7. Chinese.

PMID:
18069483
15.

Preparation and evaluation of biodegradable microspheres containing a new potent osteogenic compound and new synthetic polymers for sustained release.

Umeki N, Sato T, Harada M, Takeda J, Saito S, Iwao Y, Itai S.

Int J Pharm. 2010 Jun 15;392(1-2):42-50. doi: 10.1016/j.ijpharm.2010.03.020. Epub 2010 Mar 20.

PMID:
20227474
16.

One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.

Ohashi K, Kabasawa T, Ozeki T, Okada H.

J Control Release. 2009 Apr 2;135(1):19-24. doi: 10.1016/j.jconrel.2008.11.027. Epub 2008 Dec 7.

PMID:
19121349
17.

[The studies on the molecular mechanism of rifampin-resistant Mycobacterium tuberculosis].

Zhuang Y, He X, Zhang X.

Zhonghua Jie He He Hu Xi Za Zhi. 2000 Dec;23(12):711-4. Chinese.

PMID:
11778472
18.

Evaluation of short-term healing following sustained delivery of osteoinductive agents in a rat femur drill defect model.

Wingerter S, Tucci M, Bumgardner J, Benghuzzi H.

Biomed Sci Instrum. 2007;43:188-93.

PMID:
17487079
19.

Slow release formulations of inhaled rifampin.

Coowanitwong I, Arya V, Kulvanich P, Hochhaus G.

AAPS J. 2008 Jun;10(2):342-8. doi: 10.1208/s12248-008-9044-5. Epub 2008 Jun 27.

20.

[Rapid detection of Mycobacterium tuberculosis resistance to rifampin using DNA chip].

Jing F, Hu Z, Sun Y.

Zhonghua Jie He He Hu Xi Za Zhi. 2001 Sep;24(9):551-4. Chinese.

PMID:
11758172

Supplemental Content

Support Center